Filing Details
- Accession Number:
- 0000899243-20-018175
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-01 19:28:23
- Reporting Period:
- 2020-06-29
- Accepted Time:
- 2020-07-01 19:28:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1552451 | Myokardia Inc. | MYOK | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1104268 | B Mary Cranston | C/O Myokardia, Inc. 1000 Sierra Point Parkway Brisbane CA 94005 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-29 | 371 | $11.69 | 371 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-29 | 371 | $98.68 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-06-30 | 21,629 | $11.69 | 21,629 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-06-30 | 300 | $97.25 | 21,329 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-06-30 | 21,329 | $96.59 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-29 | 371 | $0.00 | 371 | $11.69 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2020-06-30 | 21,629 | $0.00 | 21,629 | $11.69 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
21,629 | 2026-04-10 | No | 4 | M | Direct | |
0 | 2026-04-10 | No | 4 | M | Direct |
Footnotes
- Represents the weighted average sale price of the shares sold ranging from $98.50 to $98.725 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the ranges set forth in footnotes 1 through 3.
- Represents the weighted average sale price of the shares sold ranging from $97.247 to $97.27 per share.
- Represents the weighted average sale price of the shares sold ranging from $96.24 to $97.236 per share.
- The shares subject to the option vested in 48 equal monthly installments from April 11, 2016 to April 11, 2020.